Spots Global Cancer Trial Database for The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
Official Title: The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
Study ID: NCT04196075
Conditions
Interventions
Study Description
Brief Summary: This is a prospective cohort study on the effect of Andrographis Paniculata (AP) on palliative management of patients with advanced or metastatic esophageal cancer. A total of 30 patients with locally advanced or metastatic squamous esophageal cancer will be recruited for the trial.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Outside Of US & Canada, China
Contact Details
Name: Philip WY Chiu, MD
Affiliation: Chinese University of Hong Kong
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
